Belite Bio Shares Rise After Canaccord Initiates Coverage With Buy Rating
Belite Bio (BLTE) shares rose 10% in Friday trading after Canaccord Genuity initiated coverage of the stock with a buy rating and a price target of $303.Intraday trading topped 510,150 shares, compared with the daily average of 188,179.Price: $188.98, Change: $+17.89, Percent Change: +10.46%